News Sentiment

APM sentiment intelligence

Aptorum Group Ltd Class A news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 48 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.78 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

76/100 classification confidence.

Company focus 39

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-2.5% over one week, -8.8% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Aptorum Group plans 1-for-10 reverse split, merger closing

Market Reaction

Balanced read

59/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 76/100 classification
One-week reaction -2.5% Price reacting lower
Trend fit Trend inactive -8.8% over four weeks
Fair value -61.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 29
Negative 7

Relevance

Why the article matched

Direct first
Direct company coverage 39
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 9
Market source 7
GlobeNewswire 4
Quiver Quantitative 3
FinancialContent 3
MT Newswires 2
simplywall.st 2
Investing.com 1

Event Lens

What the news is about

Classified themes
Market update 21
Earnings 13
Deals and strategy 10
Regulatory and legal 2
Analyst action 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 48
Investing.com South Africa Direct company coverage

Form 6K Aptorum Group Ltd For: 22 June By Investing.com

This article reports on the filing of Form 6K by Aptorum Group Ltd for June 22. It mentions the company's stock symbol APM and its trading performance, noting a -3.50% change. The content primarily serves as a notice of the regulatory filing and includes various market data and n

Tone
Neutral 50/100
Event
Regulatory and legal
Published
23 Jun 2026 05:39
Source
Investing.com South Africa
Finviz Direct company coverage

APM - Aptorum Group Ltd Stock Price and Quote

This article provides comprehensive financial data, news, and performance metrics for Aptorum Group Ltd (APM). It includes details on stock price, market capitalization, key financial ratios, insider ownership, and a history of corporate announcements and news related to the comp

Tone
Negative 34/100
Event
Market update
Published
01 Jun 2026 08:40
Source
Finviz
Quiver Quantitative Direct company coverage

APM | Aptorum Group Limited Class Insider Trading

This article provides an overview of Aptorum Group Limited Class A Ordinary Shares (APM) with a focus on insider trading activity, institutional holdings, and other financial data. It indicates that there has been no recent insider trading for this ticker and very limited data fo

Tone
Neutral 50/100
Event
Market update
Published
23 May 2026 18:10
Source
Quiver Quantitative
Stock Titan Direct company coverage

If You Invested $1,000 in Aptorum Group Ltd (APM)

This article analyzes the historical performance of a $1,000 investment in Aptorum Group Ltd (APM) over various periods, showing significant losses over 5 and 10 years, but a gain in the last year. It also provides a detailed overview of Aptorum Group, a clinical-stage biopharmac

Tone
Negative 18/100
Event
Market update
Published
23 Mar 2026 03:40
Source
Stock Titan
Stock Titan Direct company coverage

[6-K] Aptorum Group Ltd Current Report (Foreign Issuer) | APM SEC Filing - Form 6-K

Aptorum Group Limited filed a Form 6-K reporting the results of its 2025 annual meeting of shareholders held on March 10, 2026. The report details the voting outcomes for the re-election of Class I directors, Justin Wu and Douglas Arner, and the re-appointment of Marcum Asia CPAs

Tone
Neutral 50/100
Event
Earnings
Published
16 Mar 2026 06:09
Source
Stock Titan
Stock Titan Direct company coverage

Blood test study takes aim at glioblastoma, deadliest brain cancer

Aptorum Group and DiamiR Biosciences announced the publication of a study in "Diagnostics" demonstrating the feasibility of using microRNA-based blood tests to detect glioblastoma, the most aggressive and lethal form of brain cancer. This study, conducted with the University of P

Tone
Positive 62/100
Event
Market update
Published
10 Mar 2026 15:39
Source
Stock Titan
ChartMill Direct company coverage

Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania

Aptorum Group and DiamiR Biosciences have announced the publication of a study in Diagnostics detailing the development of microRNA-based glioblastoma biomarkers. This research, conducted with the University of Pennsylvania, outlines a minimally invasive blood plasma test for det

Tone
Positive 71/100
Event
Market update
Published
09 Mar 2026 09:40
Source
ChartMill
Stock Titan Direct company coverage

Biotech Aptorum faces Nasdaq $1 warning but keeps listing for now

Aptorum Group (NASDAQ: APM) received a Nasdaq notification for non-compliance with the $1 minimum bid price rule. The company has a 180-calendar-day grace period until September 1, 2026, to regain compliance and is exploring options, including a potential reverse stock split. The

Tone
Negative 38/100
Event
Market update
Published
07 Mar 2026 14:34
Source
Stock Titan
Stock Titan Direct company coverage

APM - Aptorum Group Ltd Latest Stock News & Market Updates

This article provides an overview of Aptorum Group Ltd (APM) stock, highlighting its focus on developing therapeutic assets for oncology and infectious diseases, and its proposed merger with DiamiR Biosciences Corp. It also details recent corporate news, including clinical trial

Tone
Positive 66/100
Event
Deals and strategy
Published
26 Feb 2026 16:51
Source
Stock Titan
Stock Titan Direct company coverage

Automated Alzheimer’s risk gene test to be vetted in DiamiR lab

Aptorum Group announced a collaboration between its subsidiary DiamiR Biosciences and Instant NanoBiosensors (INB) to validate INB's automated APOE testing platform for Alzheimer’s disease risk assessment. This validation will occur in DiamiR's CLIA-certified and CAP-accredited l

Tone
Positive 71/100
Event
Market update
Published
02 Feb 2026 12:57
Source
Stock Titan